DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ shed 6.87% to $9.49 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 4.18% to 25,709.43 and Dow Jones Industrial Average falling 1.35% to 50,866.78.
This was the stock's fifth consecutive day of losses.
Novavax Inc. closed 20.72% short of its 52-week high of $11.97, which the company achieved on February 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 2.02% to $232.77, Pfizer Inc. $(PFE)$ rose 1.36% to $26.04, and Merck & Co. Inc. $(MRK)$ rose 0.44% to $120.79.
Trading volume (4.6 M) remained 108,989 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 05, 2026 17:28 ET (21:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments